April 5, 2024
NAVIGATING THE COMPLEXITIES OF 280E, 471(C), CHAMP, & STRATEGIES FOR PSILOCYBIN SERVICE CENTERS.

An Enlightening Conversation


In this enlightening conversation, Justin Botillier, CEO of Calyx CPA in Medford, Oregon, alongside Michael Brooks, who is venturing into Oregon's burgeoning psilocybin industry, delve deep into some of the most pressing questions faced by psilocybin service centers today.



Addressing IRS Code Section 280E and Its Implications


Addressing the intricacies of Section 280E of the IRS code, they explore its profound implications on the psilocybin industry, particularly service centers, drawing parallels and distinctions with the cannabis industry's ongoing struggle.



Comprehensive Strategies to Mitigate 280E's Impact


With a comprehensive analysis, Justin provides a thorough breakdown of the strategies to mitigate 280E's impact, including the use of 471(c) and the CHAMP (Californians Helping to Alleviate Medical Problems) case as pivotal references for tax planning and business structuring.



Selecting the Appropriate Business Entity


Furthermore, the discussion covers the essential considerations for choosing the appropriate business entity, emphasizing the unique challenges and opportunities within the psilocybin sector.



Navigating Banking and Financial Operations


They also touch upon banking difficulties, offering practical advice for navigating financial operations amidst federal restrictions.



Understanding the Federal Climate and Potential Changes


Justin sheds light on the current federal climate surrounding 280E and the potential for significant legal and regulatory changes, highlighting the importance of strategic planning and robust record-keeping.



Essential Viewing for the Psilocybin Industry


This video is a must-watch for anyone involved in or considering entering the psilocybin industry, offering valuable insights into tax strategies, business planning, and the evolving federal landscape.


Whether you're an established service center, a newcomer, or simply interested in the intersection of psychedelics and business, this discussion provides critical knowledge and guidance to navigate the complexities of operating within this unique and transformative space.





Related Posts
May 7, 2026

Rescheduling, 280E, and the Fight for Retrospective Relief

The Attorney General's final order partially rescheduling marijuana has left the cannabis community with many lingering questions around 280E: when relief is effective, who qualifies, and what taxpayers can do while waiting for guidance.
Read More
May 7, 2026

Prioritizing Tax Payments When Cash Is Tight

When funds are limited, the way a taxpayer prioritizes tax obligations can affect assessed penalties, interest, and enforcement risk. Not all taxes are treated the same, and understanding that hierarchy is the starting point.
Read More
April 24, 2026

"The Single Convention Angle” to “A New Choke Point”

The DEA has placed state licensed medical marijuana into Schedule III effective April 22, 2026, ending Section 280E for qualifying businesses. But recreational cannabis rescheduling remains in a separate process. Here is what it means for cannabis operators.
Read More
Untitled UI logotext
Join our newsletter to stay up to date on features and releases.
Subscribe
We care about your data in our privacy policy.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
© 2021 calyxcpa.com. All rights reserved.